NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Cool Weather Hits AutoZone Hard: Q3 Sales Miss Expectations, Shares Drop

AutoZone profit beat estimates but sales missed; cool weather slowed demand and shares fell about 10%.

Cool Weather Hits AutoZone Hard: Q3 Sales Miss Expectations, Shares Drop
Credit: Eva Marie Uzcategui/Bloomberg
Already have an account? Sign in.
Featured/ 05/26/2026 · 1:17 PM
AZO
/ Don’t stop at just one post.

Related↓

Genuine Parts Cuts Profit Forecast, Denies Takeover Rumors as Rivals Rise
07/21/2026 · 12:19 PM

Genuine Parts Cuts Profit Forecast, Denies Takeover Rumors as Rivals Rise

Genuine Parts lowered its 2026 profit outlook amid weaker consumer demand. CEO Will Stengel denied rumors of a rival acquiring its automotive business.

/ Subscriber only
/ Read more

Feed↓

Vertex Inaxaplin Data Expands AMKD Market and Lifts Maze Outlook
Featured/ 09/22/2026 · 11:56 AM

Vertex Inaxaplin Data Expands AMKD Market and Lifts Maze Outlook

Truist calls Vertex’s Phase 2b inaxaplin data a validation of APOL1 inhibition in AMKD and sees a 100,000+ extra patient opportunity, plus positive readthrough for Maze.

/ Subscriber only
Lexeo Acquires Mantle for $8.3 Million to Expand Friedreich Ataxia Pipeline
09/22/2026 · 11:28 AM

Lexeo Acquires Mantle for $8.3 Million to Expand Friedreich Ataxia Pipeline

Deal adds oral and brain-targeted FA treatments to Lexeo’s pipeline. LX2006 gene therapy stays top priority, with pivotal data due in late 2027.

/ Subscriber only
Filana Gets FDA Green Light for Phase 2a Simufilam Study in TSC-Related Epilepsy
09/22/2026 · 11:15 AM

Filana Gets FDA Green Light for Phase 2a Simufilam Study in TSC-Related Epilepsy

FDA lifted the clinical hold on Filana’s simufilam, clearing a Phase 2a study in TSC-related epilepsy. Lucid Capital keeps a Buy rating and $8 target.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe